Skip to main content

Research Repository

Advanced Search

Diuretics and risk of lower extremity amputation amongst patients with insulin-treated type 2 diabetes – exploring the mechanism of possible sodium glucose co-transporter 2 inhibitor induced risk of lower extremity amputations

Alshnbari, Afnan; Alkharaiji, Mohammed; Anyanwagu, Uchenna; Idris, Iskandar

Authors

Afnan Alshnbari

Mohammed Alkharaiji

Uchenna Anyanwagu



Abstract

Aims and background: Sodium-glucose cotransporter-2 (SGLT2) inhibitor has been linked to an increased risk of lower extremity amputation (LEA) in patients with Type 2 Diabetes (T2D) and is known to induce volume depletion through osmotic diuresis. We investigated the potential association between diuretics use and the LEA risk in insulin-treated T2D patients. Methods and materials: A retrospective cohort study was conducted on 10,320 insulin-treated T2D patients within the UK population. Cox proportional hazard models were utilised to estimate LEA hazard ratios. Amputation risk was compared between a propensity score-matched cohort of diuretics users versus non-users over a 20-year period. Results: Among 10,320 subjects, 6454 (52.3%) were on diuretics. In the full cohort, diuretic-treated patients had significantly higher risk of LEA than the non-diuretic individuals (HR: 1.89; 95%CI: 1.34–2.68). When adjusting for possible confounding effects, a 2.3-fold higher risk of amputation was observed (aHR: 2.45; 95%CI: 1.63–3.69). In the matched cohort (n = 580), this association is marginally significant (HR: 3.33; 95%CI: 1.17–18.9; p =.029). Conclusion: While diuretic use appeared to be associated with an increased risk of LEA among insulin-treated T2D patients, this association is marginally significant after controlling for confounding factors by cohort matching. These results suggest that volume depletion may be a factor in increasing the risk of LEA amongst high-risk T2D patients, but the strength of this association is weak when adjusted for all other risk factors. Thus, patient selection is crucial when determining the safe use of agents that induce volume depletion in high risk patients with T2D.

Citation

Alshnbari, A., Alkharaiji, M., Anyanwagu, U., & Idris, I. (2020). Diuretics and risk of lower extremity amputation amongst patients with insulin-treated type 2 diabetes – exploring the mechanism of possible sodium glucose co-transporter 2 inhibitor induced risk of lower extremity amputations. Current Medical Research and Opinion, 36(12), 1985-1989. https://doi.org/10.1080/03007995.2020.1840340

Journal Article Type Article
Acceptance Date Oct 12, 2020
Online Publication Date Nov 2, 2020
Publication Date Dec 1, 2020
Deposit Date Feb 9, 2021
Journal Current Medical Research and Opinion
Print ISSN 0300-7995
Electronic ISSN 1473-4877
Publisher Taylor and Francis
Peer Reviewed Peer Reviewed
Volume 36
Issue 12
Pages 1985-1989
DOI https://doi.org/10.1080/03007995.2020.1840340
Keywords insulin, amputation, diuretic, sodium glucose co-transporter 2 inhibitor, diabetes
Public URL https://nottingham-repository.worktribe.com/output/5312560
Publisher URL https://www.tandfonline.com/doi/abs/10.1080/03007995.2020.1840340?journalCode=icmo20
Additional Information Peer Review Statement: The publishing and review policy for this title is described in its Aims & Scope.; Aim & Scope: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=icmo20; Received: 2020-05-22; Accepted: 2020-10-12; Published: 2020-11-02